Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor-risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial

Br J Haematol. 2017 Oct;179(2):342-346. doi: 10.1111/bjh.14219. Epub 2016 Jul 8.
No abstract available

Keywords: Allogeneic stem cell transplantation; Chronic lymphocytic leukaemia; Telomere length.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chromosome Aberrations
  • Clinical Trials, Phase II as Topic
  • Follow-Up Studies
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Immunoglobulin Heavy Chains / genetics
  • Immunoglobulin Variable Region / genetics
  • In Situ Hybridization, Fluorescence
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
  • Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
  • Leukemia, Lymphocytic, Chronic, B-Cell / mortality*
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy
  • Multicenter Studies as Topic
  • Mutation
  • Prognosis
  • Telomere / genetics*
  • Telomere Homeostasis / genetics*
  • Telomere Shortening
  • Transplantation, Homologous
  • Treatment Outcome

Substances

  • Immunoglobulin Heavy Chains
  • Immunoglobulin Variable Region